Bristol-Myers SquibbPublication
Mirati Therapeutics publishes application on KRAS G12S and G12C inhibitors.
The filing
Mirati Therapeutics published an application on November 12, 2026, covering KRAS G12S and G12C inhibitors. The application is available at US20260356856A1 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.